Mechanism of Action and Biological Profile of HMG CoA Reductase Inhibitors
- 1 January 1988
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 36 (Supplement) , 72-82
- https://doi.org/10.2165/00003495-198800363-00016
Abstract
Lovastatin (MK-803, mevinolin) and simvastatin (MK-733, synvinolin), 2 highly potent 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors, have been heralded as breakthrough therapy...Keywords
This publication has 21 references indexed in Scilit:
- BRAIN AND OPTIC-SYSTEM PATHOLOGY IN HYPOCHOLESTEROLEMIC DOGS TREATED WITH A COMPETITIVE INHIBITOR OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE1988
- Lovastatin, an inhibitor of cholesterol synthesis, induces hydroxymethylglutaryl-coenzyme A reductase directly on membranes of expanded smooth endoplasmic reticulum in rat hepatocytes.Proceedings of the National Academy of Sciences, 1988
- Hydroxymethylglutaryl-coenzyme A reductase exhibits graded distribution in normal and mevinolin-treated ileum.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986
- Detection of Familial Hypercholesterolemia by Assaying Functional Low-Density-Lipoprotein Receptors on LymphocytesNew England Journal of Medicine, 1986
- Hydroxymethylglutaryl-coenzyme A reductase-containing hepatocytes are distributed periportally in normal and mevinolin-treated rat livers.Proceedings of the National Academy of Sciences, 1984
- Regulation of HMG-CoA ReductasePublished by Elsevier ,1976
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976
- β-hydroxy-β-methylglutaryl coenzyme a reductase, cleavage and condensing enzymes in relation to cholesterol formation in rat liverBiochimica et Biophysica Acta, 1960
- Lipid metabolism and atherosclerosisThe American Journal of Medicine, 1951